Pharma companies in a flux over Trump's 200% tariff move on generics
ONP Summary
Trump announced a phased tariff plan on imported generic drugs with 0% duties for two years starting August 1, 2026, escalating to 100% by August 2028. Concurrently, he plans tariffs of 10–12.5% on 60+ trading partners to replace an expiring 10% global levy, citing alleged forced labor violations.
Progressive:Protectionist unilateralism — Progressive outlets emphasize Trump's unilateral tariff decisions and their impact on established suppliers like India.
Moderate:Labor-focused tariff shift — Moderate outlets present the tariffs as restructuring trade rules in response to alleged forced labor violations.
Conservative:Domestic production incentive — Conservative outlets highlight the tariffs as strategy to restore pharmaceutical manufacturing within the US.
2-year window, P 15 ...
이 뉴스, 어떠셨어요?
탭 한 번으로 반응 · 로그인 불필요